US Patent Issued to Emory University on Nov. 25 for "Inhibitors of glutathione s-transferases (GSTs) and NAD(P)H:quinone oxidoreductase 1 (NQO1), pharmaceutical compositions, and uses in managing cancer" (Georgia Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,614, issued on Nov. 25, was assigned to Emory University (Atlanta).

"Inhibitors of glutathione s-transferases (GSTs) and NAD(P)H:quinone oxidoreductase 1 (NQO1), pharmaceutical compositions, and uses in managing cancer" was invented by Keqiang Ye (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to compounds that inhibit glutathione S-transferases (GSTs) and/or NAD(P)H:quinone oxidore-ductase 1 (NQO1) for uses in treating cancer. In certain embodiments, this disclosure relates to compositions and uses of N-(thia-zol-2-yl)-carboxamide derivatives such as a N-(5-nitrothiazol-2-yl)-carboxamide derivatives for treating canc...